Anti-Human CD33 Recombinant Antibody(Lintuzumab)

Product Information

Catalog Number	YR1025
Product Name	Anti-Human CD33 Recombinant Antibody(Lintuzumab)
Molecular Name	Lintuzumab
Alias	Anti-CD33 Recombinant Antibody, Research Grade Lintuzumab
CAS Number	166089-32-3
Target	CD33[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IF, IP, Neut, FuncS, ELISA, FCM, ICC
Buffer	PBS, pH7.5
Background	Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9, 000 people a year in the United States.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price